Current use of SGLT2is, GLP-1RAs, and their combination associated with significantly reduced risk of heart failure events

Better functional outcomes but more intracranial hemorrhages seen with endovascular therapy plus medical care versus medical care alone

Prevalence of SI was 9.1 percent overall; significant associations seen for age, female gender, Asian and Black race, obesity, diabetes mellitus

Small doses of physical activity to break up sedentary time modestly attenuate postprandial glucose, insulin levels

During median follow-up of 21 years, risk reduced for Parkinson disease, secondary parkinsonism after MI

Expected gains in life expectancy larger for optimal dietary changes adopted earlier in life

Younger respondents (ages 50 to 64 years) more likely than those 65 years and older to have ever used a health app

Models developed using clinically available variables and biomarkers were well calibrated, improved reclassification of nonevents

For 2016 to 2019, less than half of individuals with live births had favorable prepregnancy cardiometabolic health

Risks for diabetes complications, mortality lower with non-vitamin K antagonist oral anticoagulants versus warfarin